Stem cell and gene therapies for diabetes mellitus
Roy Y Calne1, Shu Uin Gan, Kok Onn Lee
1Department of Medicine, Strangeways Research Laboratory, 2 Wort's Causeway, Cambridge CB1 8RN, UK. calne@hermes.cam.ac.uk
Abstract:
In this Perspectives article, we comment on the progress in experimental stem cell and gene therapies that might one day become a clinical reality for the treatment of patients with diabetes mellitus. Research on the ability of human embryonic stem cells to differentiate into islet cells has defined the developmental stages and transcription factors involved in this process. However, the clinical applications of human embryonic stem cells are limited by ethical concerns, as well as the potential for teratoma formation. As a consequence, alternative forms of stem cell therapies, such as induced pluripotent stem cells and bone marrow-derived mesenchymal stem cells, have become an area of intense study. Finally, gene therapy shows some promise for the generation of insulin-producing cells. Here, we discuss two of the most frequently used approaches: in vitro gene delivery into cells which are then transplanted into the recipient and direct delivery of genes in vivo.
Insights
Advancements in stem cell and gene therapies offer potential future treatments for diabetes mellitus. Researchers are exploring various stem cell types and gene delivery methods for generating insulin-producing cells.
Area of Science:
- Regenerative Medicine
- Endocrinology
- Molecular Therapy
Background:
- Human embryonic stem cells (hESCs) can differentiate into islet cells, but clinical use is hindered by ethical issues and teratoma risk.
- Alternative stem cell sources like induced pluripotent stem cells (iPSCs) and bone marrow-derived mesenchymal stem cells (BM-MSCs) are under investigation.
- Gene therapy presents a potential strategy for generating insulin-producing cells.
Purpose of the Study:
- To review the progress and potential of stem cell and gene therapies for diabetes mellitus treatment.
- To discuss the challenges and alternative approaches in stem cell therapy for diabetes.
- To outline gene therapy strategies for creating insulin-producing cells.
Main Methods:
- Review of current research on stem cell differentiation and gene therapy techniques.
- Discussion of ethical considerations and safety concerns related to hESCs.
- Analysis of in vitro and in vivo gene delivery methods for therapeutic applications.
Main Results:
- Significant advancements in understanding hESC differentiation into islet cells.
- Identification of iPSCs and BM-MSCs as promising alternatives to hESCs.
- Demonstration of gene therapy's potential for generating insulin-producing cells.
Conclusions:
- Stem cell and gene therapies offer a promising future for diabetes mellitus treatment.
- Overcoming ethical and safety hurdles is crucial for clinical translation.
- Further research into cell differentiation and gene delivery is warranted.
Related Concept Videos
Gene Therapy
Gene Therapy
iPS Cell Differentiation
Stem Cell Culture
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Induced Pluripotent Stem Cells
Somatic cells are...
